CAD (n = 300) | Controls (n = 300) | P | |
---|---|---|---|
Age (years) | 56.7 ± 9.9 | 56.1 ± 9.7 | 0.45 |
Sex (Male/Female) | 238/62 | 231/69 | 0.49 |
Smoking status (Ever/Never) | 84/216 | 46/254 | <0.001 |
Diabetes (Positive/Negative) | 74/226 | 42/258 | 0.001 |
Hypertension (Positive/Negative) | 163/137 | 144/156 | 0.12 |
Obesity (Positive/Negative) | 87/213 | 51/249 | 0.001 |
Hyperlipidemia (Positive/Negative) | 93/207 | 49/251 | <0.001 |
TG (mg/dL) | 192.1 ± 86.7 | 167.5 ± 77.4 | <0.001 |
TC (mg/dL) | 198.7 ± 58.4 | 185.3 ± 50.1 | 0.003 |
HDL-C (mg/dL) | 33.7 ± 11.6 | 38.9 ± 12.9 | <0.001 |
LDL-C (mg/dL) | 126.6 ± 37.4 | 112.9 ± 33.8 | <0.001 |
VLDL-C (mg/dL) | 38.4 ± 21.5 | 33.5 ± 20.3 | 0.004 |
ApoA1 (mg/dL) | 123.5 ± 22.3 | 131.9 ± 23.5 | <0.001 |
ApoB (mg/dL) | 91.4 ± 27.3 | 90.6 ± 26.7 | 0.72 |